{
"info": {
"nct_id": "NCT05541601",
"official_title": "Prospective Cohort for Early Detection of Liver Cancer",
"inclusion_criteria": "1. Patients of all genders, age >18 years\n2. Participant is willing and able to give informed consent for participation in the study.\n3. Evidence of cirrhosis CP A or B (as defined below, cirrhosis ever diagnosed), with an underlying aetiology of at least one of the following: chronic Hepatitis B Virus (HBV) infection, chronic Hepatitis C Virus (HCV) infection, alcoholic liver disease, non-alcoholic fatty liver disease or haemochromatosis\n\nCirrhosis Diagnosis Definition\n\n1. Histological assessment (Ishak stage 5 or 6) or\n2. At least one of the following:\n\ni. Validated non-invasive marker of fibrosis including fibroscan, AST to Platelet Ratio Index (APRI) score >2 or Enhanced Liver Fibrosis (ELF) score >10.48 or Fibrotest score >0.73. Fibroscan readings should be assessed by aetiology as below:\n\n* HBV: >=10 kPa\n* HCV: >=14.5 kPa\n* Alcoholic Liver Disease (ALD): >=19.5 kPa\n* Non-alcoholic fatty liver disease (NAFLD): >=15 kPa\n* Haemochromatosis: >=12kPa ii. Evidence of varices at endoscopy or imaging in the context of a patent portal vein iii. Definitive radiological evidence of cirrhosis (i.e. nodularity of liver and splenomegaly on Ultrasound/CT)\nMust have minimum age of 18 Years\nMust have maximum age of 100 Years",
"exclusion_criteria": "1. Diagnosis of current OR historical hepatocellular carcinoma\n2. Liver transplant recipients or patients on active listing for liver transplantation\n3. Child-Pugh C cirrhosis\n4. In the view of the clinician, if the patient has a co-morbidity likely to lead to death within the following 12 months\n5. In the view of the clinician, if the patient was not thought to be suitable for HCC surveillance",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. Patients of all genders, age >18 years",
"criterions": [
{
"exact_snippets": "Patients of all genders",
"criterion": "gender",
"requirements": [
{
"requirement_type": "inclusion",
"expected_value": [
"male",
"female",
"other"
]
}
]
},
{
"exact_snippets": "age >18 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "2. Participant is willing and able to give informed consent for participation in the study.",
"criterions": [
{
"exact_snippets": "Participant is willing and able to give informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
},
{
"requirement_type": "ability",
"expected_value": true
}
]
}
]
},
{
"line": "3. Evidence of cirrhosis CP A or B (as defined below, cirrhosis ever diagnosed), with an underlying aetiology of at least one of the following: chronic Hepatitis B Virus (HBV) infection, chronic Hepatitis C Virus (HCV) infection, alcoholic liver disease, non-alcoholic fatty liver disease or haemochromatosis",
"criterions": [
{
"exact_snippets": "Evidence of cirrhosis CP A or B",
"criterion": "cirrhosis",
"requirements": [
{
"requirement_type": "severity",
"expected_value": [
"CP A",
"CP B"
]
}
]
},
{
"exact_snippets": "cirrhosis ever diagnosed",
"criterion": "cirrhosis",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "underlying aetiology of at least one of the following: chronic Hepatitis B Virus (HBV) infection",
"criterion": "underlying aetiology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "chronic Hepatitis B Virus (HBV) infection"
}
]
},
{
"exact_snippets": "underlying aetiology of at least one of the following: ... chronic Hepatitis C Virus (HCV) infection",
"criterion": "underlying aetiology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "chronic Hepatitis C Virus (HCV) infection"
}
]
},
{
"exact_snippets": "underlying aetiology of at least one of the following: ... alcoholic liver disease",
"criterion": "underlying aetiology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "alcoholic liver disease"
}
]
},
{
"exact_snippets": "underlying aetiology of at least one of the following: ... non-alcoholic fatty liver disease",
"criterion": "underlying aetiology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "non-alcoholic fatty liver disease"
}
]
},
{
"exact_snippets": "underlying aetiology of at least one of the following: ... haemochromatosis",
"criterion": "underlying aetiology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "haemochromatosis"
}
]
}
]
},
{
"line": "Cirrhosis Diagnosis Definition",
"criterions": [
{
"exact_snippets": "Cirrhosis Diagnosis",
"criterion": "cirrhosis",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
}
]
},
{
"line": "1. Histological assessment (Ishak stage 5 or 6) or",
"criterions": [
{
"exact_snippets": "Histological assessment (Ishak stage 5 or 6)",
"criterion": "Ishak stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"5",
"6"
]
}
]
}
]
},
{
"line": "i. Validated non-invasive marker of fibrosis including fibroscan, AST to Platelet Ratio Index (APRI) score >2 or Enhanced Liver Fibrosis (ELF) score >10.48 or Fibrotest score >0.73. Fibroscan readings should be assessed by aetiology as below:",
"criterions": [
{
"exact_snippets": "fibroscan",
"criterion": "fibroscan",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "AST to Platelet Ratio Index (APRI) score >2",
"criterion": "AST to Platelet Ratio Index (APRI) score",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "Enhanced Liver Fibrosis (ELF) score >10.48",
"criterion": "Enhanced Liver Fibrosis (ELF) score",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"operator": ">",
"value": 10.48,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "Fibrotest score >0.73",
"criterion": "Fibrotest score",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"operator": ">",
"value": 0.73,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* HBV: >=10 kPa",
"criterions": [
{
"exact_snippets": "HBV: >=10 kPa",
"criterion": "HBV",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 10,
"unit": "kPa"
}
}
]
}
]
},
{
"line": "* HCV: >=14.5 kPa",
"criterions": [
{
"exact_snippets": "HCV: >=14.5 kPa",
"criterion": "HCV",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 14.5,
"unit": "kPa"
}
}
]
}
]
},
{
"line": "* Alcoholic Liver Disease (ALD): >=19.5 kPa",
"criterions": [
{
"exact_snippets": "Alcoholic Liver Disease (ALD): >=19.5 kPa",
"criterion": "Alcoholic Liver Disease (ALD)",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 19.5,
"unit": "kPa"
}
}
]
}
]
},
{
"line": "* Non-alcoholic fatty liver disease (NAFLD): >=15 kPa",
"criterions": [
{
"exact_snippets": "Non-alcoholic fatty liver disease (NAFLD): >=15 kPa",
"criterion": "Non-alcoholic fatty liver disease (NAFLD)",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 15,
"unit": "kPa"
}
}
]
}
]
},
{
"line": "* Haemochromatosis: >=12kPa ii. Evidence of varices at endoscopy or imaging in the context of a patent portal vein iii. Definitive radiological evidence of cirrhosis (i.e. nodularity of liver and splenomegaly on Ultrasound/CT)",
"criterions": [
{
"exact_snippets": "Haemochromatosis: >=12kPa",
"criterion": "haemochromatosis",
"requirements": [
{
"requirement_type": "severity",
"expected_value": {
"operator": ">=",
"value": 12,
"unit": "kPa"
}
}
]
},
{
"exact_snippets": "Evidence of varices at endoscopy or imaging",
"criterion": "varices",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "patent portal vein",
"criterion": "portal vein",
"requirements": [
{
"requirement_type": "patency",
"expected_value": true
}
]
},
{
"exact_snippets": "Definitive radiological evidence of cirrhosis",
"criterion": "cirrhosis",
"requirements": [
{
"requirement_type": "evidence",
"expected_value": "definitive radiological"
}
]
},
{
"exact_snippets": "nodularity of liver",
"criterion": "liver nodularity",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "splenomegaly on Ultrasound/CT",
"criterion": "splenomegaly",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 100 Years",
"criterions": [
{
"exact_snippets": "maximum age of 100 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 100,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Diagnosis of current OR historical hepatocellular carcinoma",
"criterions": [
{
"exact_snippets": "Diagnosis of current OR historical hepatocellular carcinoma",
"criterion": "hepatocellular carcinoma",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": [
"current",
"historical"
]
}
]
}
]
},
{
"line": "2. Liver transplant recipients or patients on active listing for liver transplantation",
"criterions": [
{
"exact_snippets": "Liver transplant recipients",
"criterion": "liver transplant recipient",
"requirements": [
{
"requirement_type": "status",
"expected_value": true
}
]
},
{
"exact_snippets": "patients on active listing for liver transplantation",
"criterion": "active listing for liver transplantation",
"requirements": [
{
"requirement_type": "status",
"expected_value": true
}
]
}
]
},
{
"line": "3. Child-Pugh C cirrhosis",
"criterions": [
{
"exact_snippets": "Child-Pugh C cirrhosis",
"criterion": "Child-Pugh classification",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "C"
}
]
}
]
},
{
"line": "4. In the view of the clinician, if the patient has a co-morbidity likely to lead to death within the following 12 months",
"criterions": [
{
"exact_snippets": "co-morbidity likely to lead to death within the following 12 months",
"criterion": "co-morbidity",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "likely to lead to death within the following 12 months"
}
]
}
]
},
{
"line": "5. In the view of the clinician, if the patient was not thought to be suitable for HCC surveillance",
"criterions": [
{
"exact_snippets": "patient was not thought to be suitable for HCC surveillance",
"criterion": "suitability for HCC surveillance",
"requirements": [
{
"requirement_type": "suitability",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "2. At least one of the following:",
"criterions": []
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}